| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.7M | +98.4% |
| SG&A Expense | $6.0M | +47.9% |
| Operating Income | -$9.7M | -63.8% |
| Pre-tax Income | -$9.3M | -58.1% |
| Income Tax | -$105K | — |
| Net Income | -$9.2M | -56.3% |
| EPS (Basic) | -$1.09 | -22.5% |
| EPS (Diluted) | -$1.09 | -22.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.0M | -68.7% |
| Current Assets | $3.9M | -63.6% |
| Total Assets | $6.0M | -54.2% |
| Current Liabilities | $1.6M | +17.5% |
| Total Liabilities | $2.6M | -1.5% |
| Stockholders' Equity | $3.4M | -67.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.5M | +23.6% |
| Capital Expenditures | $170K | -57.1% |
| Investing Cash Flow | -$150K | +58.2% |
| Financing Cash Flow | -$28K | -100.1% |
| Free Cash Flow | -$6.7M | +25.1% |